"Neuralgia, Postherpetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus (HERPESVIRUS 3, HUMAN). The two forms of the condition preceding the pain are HERPES ZOSTER OTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.
| Descriptor ID |
D051474
|
| MeSH Number(s) |
C10.668.829.600.550 C23.888.592.612.664.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neuralgia, Postherpetic".
Below are MeSH descriptors whose meaning is more specific than "Neuralgia, Postherpetic".
This graph shows the total number of publications written about "Neuralgia, Postherpetic" by people in this website by year, and whether "Neuralgia, Postherpetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuralgia, Postherpetic" by people in Profiles.
-
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged =50 years in the United States. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2327145.
-
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ. 2023 Nov 08; 383:e076321.
-
Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention. Vaccine. 2019 08 23; 37(36):5422-5427.
-
Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. Vaccine. 2019 06 06; 37(26):3478-3484.
-
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. J Infect Dis. 2015 Oct 15; 212(8):1222-31.
-
Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster. Pharmacoeconomics. 2009; 27(12):1005-16.
-
National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S216-23.
-
Community and patient values for preventing herpes zoster. Pharmacoeconomics. 2008; 26(3):235-49.